CDH2 and breast cancer: The expression of epithelial phenotype-associated molecules (e.g., E-cadherin) was increased, as also reported for BC [22], while the expression of mesenchymal phenotype-associated molecules (e.g., N-cadherin and ZEB1) was suppressed.